Remember meForgot password?
    Log in with Twitter

article imageHillary Clinton pledges funding for Alzheimer's cure by 2025

By Marcus Hondro     Dec 25, 2015 in Health
While Hillary Clinton is focusing on the issues polls show Americans are most concerned with, the economy and national security, she is also working in other areas. Last week she announced funding plans for Alzheimer's research.
Alzheimer's cure by 2025
On Tuesday the Democratic front-runner for president said she'd dramatically increase the funding for Alzheimer's Disease research with a view to finding a cure for the illness; at the moment the effects of the disease can be mitigated but there is no known cure and most victims die within eight years of their diagnosis.
Ms. Clinton said that over a 10-year period she would earmark $2 billion per year toward research and that the money for the funding increase — up to four times the annual sum now being spent on Alzheimer's research in the U.S. — would come through taxes on wealthier Americans.
"We owe it to the millions of families who stay up at night worrying about their loved ones afflicted by this terrible disease and facing the hard reality of the long goodbye to make research investments that will prevent, effectively treat and make a cure possible by 2025," she said.
Alzheimer's research advances
The Wall Street Journal spoke with Republican Newt Gingrich, who supports Clinton's proposal and was hopeful his party's candidates would make such measures as Clinton proposed a part of their platform, too. He told the WSJ he hoped that GOP candidates would "look seriously at either matching or improving her approach."
There have been a raft of advances in Alzheimer's research in recent years, including the drug aducanumab that researchers said has shown promise in reversing the build-up of amyloid plaque in the brain, believed to be the cause of Alzheimer's. Another drug being researched is Namzaric. There has also been advances in early detection of the debilitating cognitive disease through the use of MRI screening.
In November, promising research was announced by Dr. Joy Yu of the U.S. biotechnology company Genentech Inc.. Dr. Yu said they found a way of attaching antibodies to transferrin, which takes iron into the brain. Antibodies delivered to the brain could prevent a build-up of those amyloid beta toxins, which is what is stopping neurons in the brain from firing. That research, too, is ongoing.
As many as 36 million people globally suffer from Alzheimer's, some 5 million of them in the U.S. alone. There's never been a Alzheimer's Disease survivor.
More about Hillary clinton, Alzheimer's disease, cure for Alzheimer's
More news from
Latest News
Top News